Trinity Biotech plc Strategic Asset Allocation Index
Trinity Biotech plc strategic asset allocation index. Trinity Biotech plc (TRIB) has a Strategic Asset Allocation Index of 39.6% as of June 2022. Strategic assets (PP&E of $6.26 Million plus long-term investments of $-) total $6.26 Million, measured against net assets of $15.82 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how tangible is Trinity Biotech plc's equity to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Trinity Biotech plc (2000–2019)
Strategic asset allocation index of Trinity Biotech plc from 2000 to 2019. This chart shows how Trinity Biotech plc's Strategic Asset Allocation Index has evolved across 20 annual periods from 2000 to 2019. As of June 2022, the index stands at 39.6%, representing strategic assets of $6.26 Million against net assets of $15.82 Million USD.
Trinity Biotech plc Strategic Asset Allocation Index by Year (2000–2019)
Trinity Biotech plc strategic asset allocation index by year from 2000 to 2019. The table below presents the year-by-year Strategic Asset Allocation Index for Trinity Biotech plc from 2000 to 2019, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see TRIB company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 197.1% | $9.29 Million | $9.29 Million | $- | $4.71 Million | ▲ +184.9 pp |
| 2018 | 12.2% | $5.36 Million | $5.36 Million | $- | $44.05 Million | ▲ +2.7 pp |
| 2017 | 9.4% | $6.16 Million | $5.80 Million | $360.00K | $65.20 Million | ▼ -2.9 pp |
| 2016 | 12.3% | $13.40 Million | $13.40 Million | $0.00 | $108.73 Million | ▲ +0.5 pp |
| 2015 | 11.9% | $25.35 Million | $20.66 Million | $4.69 Million | $213.89 Million | ▲ +0.4 pp |
| 2014 | 11.5% | $22.57 Million | $17.88 Million | $4.69 Million | $196.97 Million | ▲ +4.4 pp |
| 2013 | 7.1% | $12.99 Million | $12.99 Million | $- | $183.01 Million | ▲ +1.9 pp |
| 2012 | 5.2% | $8.88 Million | $8.88 Million | $- | $169.38 Million | ▲ +0.2 pp |
| 2011 | 5.0% | $7.63 Million | $7.63 Million | $- | $151.33 Million | ▲ +0.8 pp |
| 2010 | 4.2% | $6.00 Million | $6.00 Million | $- | $141.29 Million | ▼ -11.1 pp |
| 2009 | 15.3% | $12.17 Million | $12.17 Million | $- | $79.34 Million | ▼ -2.6 pp |
| 2008 | 18.0% | $11.86 Million | $11.86 Million | $- | $65.91 Million | ▼ -1.3 pp |
| 2007 | 19.3% | $26.41 Million | $26.41 Million | $- | $136.84 Million | ▲ +6.0 pp |
| 2006 | 13.3% | $22.25 Million | $22.25 Million | $- | $167.26 Million | ▼ -1.1 pp |
| 2005 | 14.4% | $19.20 Million | $19.20 Million | $- | $133.62 Million | ▲ +0.6 pp |
| 2004 | 13.7% | $15.94 Million | $15.94 Million | $- | $116.14 Million | ▼ -3.3 pp |
| 2003 | 17.0% | $13.66 Million | $13.66 Million | $- | $80.26 Million | ▲ +1.3 pp |
| 2002 | 15.7% | $9.88 Million | $9.88 Million | $- | $62.91 Million | ▲ +5.1 pp |
| 2001 | 10.6% | $5.97 Million | $5.97 Million | $- | $56.53 Million | ▲ +0.6 pp |
| 2000 | 9.9% | $5.47 Million | $5.47 Million | $- | $55.04 Million | — |